Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Severe and Acute Sciatica
NCT00470509Phase 2Completed
- Start
- May 2005
- Primary completion
- Jan 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of adalimumab in Sciatica. Started May 2005; status: completed.
02
Drugs
03
Conditions
Sciatica
Beyond the preview
Go deeper on NCT00470509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00470509.